Comment on: Effects of isoniazid resistance on TB treatment outcomes under programmatic conditions in a high-TB and -HIV setting: a prospective multicentre study

J Antimicrob Chemother. 2018 Jun 1;73(6):1733-1734. doi: 10.1093/jac/dkx497.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antitubercular Agents
  • HIV Infections*
  • Humans
  • Isoniazid*
  • Prospective Studies
  • Treatment Outcome

Substances

  • Antitubercular Agents
  • Isoniazid